Abstract:Objective To explore the effect and safety of different maintenance doses of Caffeine Citrate in the treatment of premature infants with gestational age <34 weeks with apnea.Methods A total of 80 premature infants with apnea less than 34 weeks of gestational age admitted to Yingtan People′ Hospital from February 2019 to February 2020 were selected as the research objects and divided into the control group and the observation group according to the random number table method, with 40 patients in each group.Both groups were treated with Caffeine Citrate as a therapeutic agent.The dosage of the control group was 5 mg/(kg·d), and the dose of the observation group was 10 mg/(kg·d).The total effective rate, treatment time, number of apnea at different stages and the probability of adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was higher than that in the control group, and the difference was statistically significant (P<0.05).The mechanical ventilation time, low-flow oxygen ventilation time and hospital stay time of the observation group were shorter than those of the control group, and the differences were statistically significant (P<0.05).The number of apnea after 24, 48, 72 hours in the observation group was fewer than that in the control group, and the differences were statistically significant (P<0.05).The total incidence of adverse reactions of the observation group was lower than that of the control group, and the difference was statistically significant (P<0.05).Conclusion The maintenance dose of 10 mg/(kg·d) of Caffeine Citrate is more effective in the treatment of premature infants with apnea <34 weeks of gestational age and less adverse reactions.
黄瑶. 不同维持量枸橼酸咖啡因治疗胎龄<34周早产儿呼吸暂停的效果与安全性[J]. 中国当代医药, 2021, 28(8): 102-104.
HUANG Yao. Effect and safety of different maintenance doses of Caffeine Citrate in the treatment of premature infants with gestational age <34 weeks with apnea. 中国当代医药, 2021, 28(8): 102-104.